1st Ketamine-Assisted Psychotherapy International Association Summit
OVERVIEW
We’re pleased to welcome you all to the 1st International Association Summit on Ketamine-Assisted Psychotherapy (KAP), co-organized by the Ketamine Research Foundation and Clinica Synaptica. This summit aims to foster and generate a community of practitioners that are well-informed, ethically grounded, and clinically prepared to deliver KAP with the highest standards of care. By bringing together leading voices in psychiatry, pharmacology, and psychotherapy from across the world, we hope to create a space for open dialogue, shared learning, and meaningful collaboration — one that will continue to grow well beyond these walls. Whether you are new to ketamine-assisted approaches or already integrating them into your practice, we are glad you are here and look forward to building this community together.
Below you can find the full programme for the 3-day summit, and more information about the speakers and staff that have made this event possible. Contact information is also available at the bottom of the document.
Certification
Attendance to at least 90% (not counting the oral presentations for the abstracts) of the congress is necessary for obtaining the certificate of completion. This will be taken through a digital sign-in code on entry.
Thank you and see you in Barcelona!
Scientific Program
FRIDAY – FULL DAY
BLOCK I · PREPARATION
09:00 – 09:20
Registration
09:20 – 09:40
Opening of the Summit
• Welcome
• Objectives and structure
🎤 Morning Keynote
09:40 – 10:30
Foundations and Boundaries of Ketamine-Assisted Psychotherapy – Phil Wolfson
Clinical Sessions – Preparation
10:30 – 11:00
Clinical Assessment & Screening after 4 years at Clínica Synaptica — Joan Obiols
☕ Break 11:00 – 11:30
11:30 – 12:10
Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review — Celia Morgan
12:10 – 12:50
Setting the Stage: Useful approaches to ketamine / psychedelic preparation — Marc Aixalà
12:50 – 13:30
Relational Preparation: Building Safety and Connection as the Foundation for Healing — Lisa Gold
🧠 Morning Reflection Panel & Audience Discussion (Wrap-up)
13:30 – 14:00
Preparation in Practice: Key Clinical Decisions
Panel – Joan Obiols, Celia Morgan, Marc Aixalà, Lisa Gold and Phil Wolfson
🍽 Lunch 14:00 – 15:15
🎤 Early Afternoon Keynote
15:15 – 16:15
Chris Timmermann
Psychedelic Therapy as the Reconstruction of Meaning: A Theory informed by Neuroscience.
🧪 Oral Presentations – Call for Abstracts (Session I)
16:15 – 17:45 – moderated by Noel Garcia
• 4 selected presentations (15’ each)
• 30’ moderated Q&A and audience discussion
• Focus: Preparation & Clinical Foundations
🧠 Afternoon Reflection & Audience Discussion (Wrap-up)
17:45 – 18:30
Panel – Celia Morgan, Chris Timmerman, José Carlos Bouso and Phil Wolfson
SATURDAY – FULL DAY
🌊 BLOCK II · THE KAP EXPERIENCE
🎤 Morning Keynote
09:30 – 10:15
Delivering the KAP Experience in Real-World Clinical Settings – Irene Pérez & Marta Martín
Clinical Sessions – The KAP Experience
10:15 – 11:00
Pharmacology & Administration — José Carlos Bouso
☕ Break 11:00 – 11:30
11:30 – 12:15
Working Inside the KAP Session — Phil Wolfson
🧪 Oral Presentations – Call for Abstracts (Session II)
12:15 – 13:45 – moderated by Marta Martín
• 4 selected presentations (15’ each)
• 30’ moderated Q&A and audience discussion
• Focus: The KAP Session & Therapeutic Process
🧠 Morning Reflection & Audience Discussion (Wrap-up)
13:45 – 14:15
Clinical Challenges During the KAP Session
Panel: Irene Pérez, Marta Martín, Phil Wolfson & José Carlos Bouso
🍽 Lunch 14:15 – 15:30
🎤 Early Afternoon Keynote (Online)
15:30 – 16:30
Ron Siegel (by Zoom)
Mindfulness, Ketamine and Psychedelic States
🧩 Breakout Groups
16:30 – 17:45
Breakout Groups: Translating Experience Into Clinical Practice
• Small-group facilitated discussions
• Case-based clinical dilemmas
• Integration of morning and keynote content
🧠 Afternoon Wrap-up (Plenary)
17:45 – 18:30
Plenary Synthesis & Audience Reflections
Panel: Breakout groups coordinators & Phil Wolfson
SUNDAY – MORNING
🌱 BLOCK III · INTEGRATION & SYSTEMS
🕘 09:00 – 14:30
🎤 Morning Keynote
09:00 – 09:50
From Acute Effects to Long-Term Outcomes – Celia Morgan
Clinical Sessions – Integration
09:50 – 10:15
The Clínica Synaptica Model of Integration – Estefania Moreno
10:15 – 10:40
Beyond the Void: Grief Integration in the Age of KAP – Débora González
10:40 – 11:15
Follow-up: tools and techniques to foster integration – Marc Aixalà
☕ Break 11:15 – 11:45
🎤 Systems Keynote
11:45 – 12:15
KAP in the Norwegian Public Health System – Lowan Stewart
🧪 Oral Presentations – Call for Abstracts (Session III)
12:15 – 13:45 – moderated by Mery Peña
• 4 selected presentations (15’ each)
• 30’ moderated Q&A and audience discussion
• Focus: Integration, Systems & Future Directions
🧠 Final Reflection & Closing
13:45 – 14:30
Wrap-Up& Closing: Integration as the Missing Link
Celia Morgan, Lowan Stewart, Phil Wolsfon, Débora González, Estefania Moreno & Marc Aixalà
Speakers and staff:
- Phil Wolfson; Psychiatrist, Ketamine Research Foundation.
- Celia Morgan; Professor and Researcher, University of Exeter.
- Joan Obiols; Psychiatrist, Clinica Synaptica.
- Chris Timmerman; Researcher, Imperial College London.
- Lisa Gold; Psychologist, The Arizona Relationship Institute.
- Marc Aixalà; Psychologist, ICEERS Barcelona.
- Ron Siegel, Professor, Harvard Medical School.
- Lowan Stewart; Emergency Doctor, co-lead for NorRAD, the Norwegian Network for Rapid-Acting Antidepressants.
- Estefanía Moreno; Integrative Doctor, Clínica Synaptica.
- Debora Gonzalez; Doctor in Pharmacology, Clínica Synaptica.
- José Carlos Bouso; Doctor in Pharmacology, Clínica Synaptica.
- Irene Perez; Art Therapist and TRE® facilitator, Clínica Synaptica.
- Marta Martín Islas; Psychologist, Clínica Synaptica.
- Noel Garcia; Psychologist, Clínica Synaptica.
- Mery Peña; Doctor in Medicine and Surgery, Clínica Synaptica.
Administration and Organization
This congress has been made possible through the collaboration of Clínica Synaptica and the Ketamine Research Foundation, thanks to:
- Òscar Parés; CEO of Clínica Synaptica
- Phil Wolfson; CEO of the Ketamine Research Foundation
For any doubts please contact Marta Martín at martamartin@clinicasynaptica.com or whatsapp at +34 648579135.
Payment and Registration
Payment and registration are can be accessed through: